ArticleCureus2024
Cracking the Codes for Congenital Diarrhea and Enteropathies (CoDEs): A Case Report and Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LEF1 gene mutation impairs the intestinal barrier and causes diarrhea.Molecular and cellular pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital diarrhea and enteropathies (CoDEs) condition is a rare cause of chronic diarrhea in infants that can be challenging to diagnose. This article discusses key signs to recognize in considering a CoDEs diagnosis and provides an overview of the diagnostic process. We report a late preterm twin infant with intractable watery diarrhea starting shortly after birth. The infant was born from a twin pregnancy to non-consanguineous parents with an unremarkable family history. His twin brother had no complications after birth and continued to thrive. The patient initially presented with bloody stools, leading to a suspected diagnosis of necrotizing enterocolitis or cow's milk protein-induced allergic colitis. However, the emergence of profuse and watery diarrhea, failure to thrive, and hypernatremic dehydration shifted the suspicion toward malabsorptive diarrhea. An extensive workup was significant for hypernatremic metabolic acidosis and positive stool-reducing substances. Several trials of protein-hydrolysate and elemental amino acid-based formulas failed to improve symptoms. However, stool consistency improved with a trial of a carbohydrate-free, hydrolyzed protein-based formula (3232A). As a diagnostic test for specific carbohydrate malabsorption, the infant was challenged with glucose supplementation followed by fructose supplementation; his stool consistency worsened with the glucose challenge but improved with the fructose challenge. His stool pH and reducing substances were abnormal after the glucose challenge and normalized after the fructose challenge, thus indicating a clinical diagnosis of glucose-galactose malabsorption (GGM). At the time of discharge, the infant had documented weight gain and formed stools on carbohydrate-free, hydrolyzed protein-based formula (3232A) supplemented with fructose. At one-year follow-up after discharge, he continued to thrive with normal bowel movements. Outpatient genetic testing confirmed our diagnosis of GGM. GGM should be considered in infants with severe protracted, non-infectious, watery diarrhea lasting longer than two weeks. Early diagnosis and management of infants with GGM with a carbohydrate-free formula with specific carbohydrate supplementation are essential to prevent complications and ensure optimal growth and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.